ACRV · Insider trading · 13F holders · Congress trades
Acrivon Therapeutics, Inc. (ACRV)
Who is buying and selling ACRV: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 1
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $40K
- Congress trades, 12 months
- 0
ACRV at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 6 ACRV insiders filed 9 sales worth $40K on SEC Form 4, and no open-market purchases.
- 1 13F filer hold ACRV among their 50 largest positions, worth $4.1M combined. The biggest bets by portfolio weight are Sands Capital Alternatives, LLC (0.7%). In their latest 13Fs, 0 managers opened a new position and 1 added to one.
- No member of Congress has disclosed a trade in ACRV.
- ACRV last closed at $1.76 on Oct 29, 2026.
ACRV insider trading
Between Aug 1, 2026 and Oct 29, 2026, 6 ACRV insiders filed 9 sales worth $40K on SEC Form 4, and no open-market purchases.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Miller Mary | Chief Legal Officer | Sale | 513 | $1.84 | $943.92 | SEC |
| Oct 7, 2026 | Miller Mary | Chief Legal Officer | Sale | 294 | $1.99 | $585.06 | SEC |
| Aug 27, 2026 | Blume-Jensen Peter | President and CEO, Director | Sale | 14,036 | $2.21 | $31K | SEC |
| Aug 20, 2026 | Blume-Jensen Peter | President and CEO, Director | Sale | 1,713 | $2.01 | $3K | SEC |
| Aug 20, 2026 | Devroe Eric | Chief Operating Officer | Sale | 604 | $2.01 | $1K | SEC |
| Aug 20, 2026 | Gamelin Erick | Chief Development Officer | Sale | 400 | $2.01 | $804.00 | SEC |
| Aug 20, 2026 | Miller Mary | Chief Legal Officer | Sale | 185 | $2.01 | $371.85 | SEC |
| Aug 20, 2026 | Peterson Katharine | Chief Accounting Officer | Sale | 101 | $2.01 | $203.01 | SEC |
| Aug 6, 2026 | Levy Adam D. | Chief Financial Officer | Sale | 1,142 | $1.57 | $2K | SEC |
Who owns ACRV? Hedge funds and superinvestors
1 13F filer hold ACRV among their 50 largest positions, worth $4.1M combined. The biggest bets by portfolio weight are Sands Capital Alternatives, LLC (0.7%). In their latest 13Fs, 0 managers opened a new position and 1 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Sands Capital Alternatives, LLCHedge fund | 0.7% | $4.1M | 2,289,271 | +7.9% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 1). Screen ACRV in the grand portfolio →
ACRV stock trades by members of Congress
No member of Congress has disclosed a trade in ACRV.
ACRV questions and answers
Are insiders buying ACRV stock?
Between Aug 1, 2026 and Oct 29, 2026, 6 ACRV insiders filed 9 sales worth $40K on SEC Form 4, and no open-market purchases.
Which hedge funds own ACRV?
1 13F filer hold ACRV among their 50 largest positions, worth $4.1M combined. The biggest bets by portfolio weight are Sands Capital Alternatives, LLC (0.7%). In their latest 13Fs, 0 managers opened a new position and 1 added to one.
Has Congress traded ACRV?
No member of Congress has disclosed a trade in ACRV.
Who is the largest holder of ACRV?
Among 13F filers, Sands Capital Alternatives, LLC reports the largest ACRV position, $4.1M (2,289,271 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Sands Capital Alternatives, LLC's: 0.7% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.